Patents by Inventor Urs Albert Meyer

Urs Albert Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Primers targeted to NAT2 gene for detection of poor metabolizers of drugs
    Patent number: 5844108
    Abstract: A method for the detection of poor metabolizers of drugs using PCR technology is described comprising a) optionally amplifying a gene coding for an enzyme known to be responsible for the metabolization of drugs, thereby separating it from possible closely related pseudogens, b) amplifying different allelic forms of the gene of step a) and c) detecting the product of step b). Primers for amplification of the genes responsible for the debrisoquine or acetylation phenotype are also disclosed.
    Type: Grant
    Filed: November 6, 1996
    Date of Patent: December 1, 1998
    Assignee: Roche Molecular Systems, Inc.
    Inventor: Urs Albert Meyer
  • Primers targeted to CYP2D6 gene for detecting poor metabolizers of drugs
    Patent number: 5648482
    Abstract: A method for the detection of poor metabolizers of drugs using PCR technology is described comprising a) optionally amplifying a gene coding for an enzyme known to be responsible for the metabolization of drugs, thereby separating it from possible closely related pseudogens,b) amplifying different allelic forms of the gene of step a) and c) detecting the product of step b). Primers for amplification of the genes responsible for the debrisoquine or acetylation phenotype are also disclosed.
    Type: Grant
    Filed: March 2, 1994
    Date of Patent: July 15, 1997
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Urs Albert Meyer